Kathleen Goin is COO at PALVELLA THERAPEUTICS, INC. (PVLA). They have made 1 open-market trade across 1 company since 2025, most recently 2026-09-16.
CIK 0001912570
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PVLA | 1,654 | $200K |
Shares reported on the most recent Form 4, priced at the 2026-09-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PVLA | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $152.24 | $655K | -8.7% | — | — |
| PVLA | SELL · 10b5-1 | 2026-08-19 | 2026-08-20 | $152.21 | $655K | +2.5% | +4.7% | — |
| PVLA | SELL · 10b5-1 | 2026-07-15 | 2026-07-17 | $149.28 | $642K | -7.9% | -1.1% | -17.5% |
| PVLA | SELL · 10b5-1 | 2026-06-17 | 2026-06-22 | $110.73 | $476K | +22.7% | +19.1% | +28.7% |
| PVLA | SELL · 10b5-1 | 2026-05-20 | 2026-05-22 | $110.56 | $476K | +0.4% | +3.2% | +23.8% |
| PVLA | SELL · 10b5-1 | 2026-04-15 | 2026-04-17 | $127.24 | $547K | -5.7% | -19.2% | +13.4% |
| PVLA | SELL · 10b5-1 | 2026-03-18 | 2026-03-20 | $117.99 | $1.0M | +5.3% | +13.1% | -1.1% |
| PVLA | SELL · 10b5-1 | 2026-02-18 | 2026-02-20 | $79.40 | $342K | +59.0% | +37.4% | +36.3% |
| PVLA | SELL | 2026-01-21 | 2026-01-23 | $97.63 | $420K | -3.3% | +3.6% | +49.8% |
| PVLA | SELL · 10b5-1 | 2025-12-17 | 2025-12-19 | $96.47 | $830K | +0.6% | -1.7% | +14.2% |
| PVLA | SELL · 10b5-1 | 2025-11-19 | 2025-11-21 | $86.34 | $613K | -2.3% | +13.6% | -14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.